Robert A. Holt
Burnaby, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.
Journal: Nature cancer
Published: April 29, 2026
A gene-editing method generates immunotherapeutic CAR T cells in the body.
Journal: Nature
Published: March 19, 2026
Self-Multimerization of mRNA LNP-Derived Antigen Improves Antibody Responses.
Journal: Vaccines
Published: November 26, 2025
A De Novo Algorithm for Allele Reconstruction from Oxford Nanopore Amplicon Reads, with Application to CYP2D6.
Journal: Bioinformatics (Oxford, England)
Published: November 13, 2025
Comprehensive self-antigen screening to assess cross-reactivity in promiscuous T-cell receptors.
Journal: Frontiers in immunology
Published: October 07, 2025
Identification of novel DNA sequence motifs that modulate transcription in T cells.
Journal: BMC genomics
Published: August 12, 2025
Applying principles of vaccine development to oncomicrobial vaccines.
Journal: Blood advances
Published: April 28, 2025
Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869.
Journal: International journal of molecular sciences
Published: October 12, 2024
Direct in vivo CAR T cell engineering.
Journal: Trends in pharmacological sciences
Published: February 23, 2024
A synthetic cytotoxic T cell platform for rapidly prototyping TCR function.
Journal: NPJ precision oncology
Published: January 02, 2024
A Synthetic Cytotoxic T cell Platform for Rapidly Prototyping TCR Function.
Journal: bioRxiv : the preprint server for biology
Published: December 04, 2023
Last Updated: 09/26/2026